Bio-Techne
TECH
#2107
Rank
HK$69.21 B
Marketcap
HK$444.25
Share price
0.19%
Change (1 day)
-23.72%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): HK$3.88

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is HK$3.89. In 2024 the company made an earnings per share (EPS) of HK$7.78 a decrease over its 2023 EPS that were of HK$11.05.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$3.88-50.14%
2024HK$7.78-29.58%
2023HK$11.05-14.97%
2022HK$12.9924.16%
2021HK$10.4617.98%
2020HK$8.87-10.94%
2019HK$9.96101.57%
2018HK$4.94-16.99%
2017HK$5.9545.02%
2016HK$4.10-20.97%
2015HK$5.19-14.97%
2014HK$6.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$134.91 3,368.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-HK$189.14-4,962.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$43.34 1,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
HK$37.97 876.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
HK$14.54 273.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
HK$58.82 1,412.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.63-142.00%๐Ÿ‡บ๐Ÿ‡ธ USA